يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Derk-Jan A. de Groot"', وقت الاستعلام: 1.12s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
    Pancreatology, 21, 163-169
    Pancreatology, 21(1), 163-169. Elsevier
    Pancreatology, 21, 1, pp. 163-169
    Pancreatology, 21(1), 163-169. S. Karger AG
    Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

    وصف الملف: application/pdf

  3. 3
  4. 4

    المساهمون: Surgery, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, APH - Methodology, Oncology, APH - Quality of Care, Ear, Nose and Throat, Graduate School, Pathology, Gastroenterology and Hepatology, CCA -Cancer Center Amsterdam, Gastroenterology and hepatology, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Gastroenterology & Hepatology, Medical Oncology, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9)

    المصدر: MacKay, T M, Smits, F J, Latenstein, A E J, Bogte, A, Bonsing, B A, Bos, H, Bosscha, K, Brosens, L A A, Hol, L, Busch, O R C, Creemers, G J, Curvers, W L, Den Dulk, M, Van Dieren, S, Van Driel, L M J W, Festen, S, Van Geenen, E J M, Van Der Geest, L G, De Groot, D J A, De Groot, J W B, Haj Mohammad, N, Haberkorn, B C M, Haver, J T, Van Der Harst, E, Hemmink, G J M, De Hingh, I H, Hoge, C, Homs, M Y V, Van Huijgevoort, N C, Jacobs, M A J M, Kerver, E D, Liem, M S L, Los, M, Lubbinge, H, Luelmo, S A C, De Meijer, V E, Mekenkamp, L, Molenaar, I Q, Van Oijen, M G H, Patijn, G A, Quispel, R, Van Rijssen, L B, Römkens, T E H, Van Santvoort, H C, Schreinemakers, J M J, Schut, H, Seerden, T, Stommel, M W J, Ten Tije, A J, Venneman, N G, Verdonk, R C, Verheij, J, Van Vilsteren, F G I, De Vos-Geelen, J, Vulink, A, Wientjes, C, Wit, F, Wessels, F J, Zonderhuis, B, Van Werkhoven, C H, Van Hooft, J E, Van Eijck, C H J, Wilmink, J W, Van Laarhoven, H W M & Besselink, M G 2020, ' Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1) : A multicenter stepped-wedge cluster randomized controlled trial ', Trials, vol. 21, no. 1, 334 . https://doi.org/10.1186/s13063-020-4180-zTest
    Trials, 21
    Trials
    Trials, 21(1):334. BioMed Central
    TRIALS, 21(1):334. BMC
    Trials, 21(1). BMC
    Trials, 21(1). BioMed Central Ltd.
    Trials, 21, 1
    Trials, Vol 21, Iss 1, Pp 1-18 (2020)
    Trials, 21(1). BioMed Central
    Trials, 21(1):334. BioMed Central Ltd

    مصطلحات موضوعية: Male, Survival, Medicine (miscellaneous), GUIDELINES, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Study Protocol, 0302 clinical medicine, Superiority Trial, Randomized controlled trial, DESIGN, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Cluster Analysis, Multicenter Studies as Topic, Pharmacology (medical), 030212 general & internal medicine, Child, Netherlands, Randomized Controlled Trials as Topic, Aged, 80 and over, lcsh:R5-920, Pancreatic enzyme replacement therapy, STATEMENT, Palliative Care, Middle Aged, Neoadjuvant Therapy, Biliary Tract Surgical Procedures, Treatment Outcome, 030220 oncology & carcinogenesis, Child, Preschool, Drainage, Female, Stents, lcsh:Medicine (General), Carcinoma, Pancreatic Ductal, Adult, Quality of life, medicine.medical_specialty, Best practices, Registry, RESECTION, Referral, Adolescent, Best practice, Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0], Biliary drainage, Disease cluster, Pancreaticoduodenectomy, 03 medical and health sciences, Young Adult, Quality of life (healthcare), SDG 3 - Good Health and Well-being, Pancreatic cancer, medicine, Journal Article, Humans, Chemotherapy, Enzyme Replacement Therapy, Stepped-wedge cluster randomized controlled trial, Aged, business.industry, Health Plan Implementation, Infant, Newborn, Infant, Guideline, medicine.disease, Pancreatic Neoplasms, SAMPLE-SIZE, Implementation, Emergency medicine, Patient Compliance, business

    وصف الملف: application/pdf; text/plain

  5. 5

    المساهمون: Oncology, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Epidemiology and Data Science, APH - Methodology, Surgery, AGEM - Digestive immunity, Medical Oncology, Rehabilitation Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers, Medical oncology

    المصدر: BMC Cancer, 19
    BMC cancer, 19(1):390. BioMed Central
    BMC Cancer, 19(1). BioMed Central
    Rovers, K P, Bakkers, C, Simkens, G A A M, Burger, J W A, Nienhuijs, S W, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, Ayez, N, de Boer, N L, van Meerten, E, Tuynman, J B, Kusters, M, Sluiter, N R, Verheul, H M W, van der Vliet, H J, Wiezer, M J, Boerma, D, Wassenaar, E C E, Los, M, Hunting, C B, Aalbers, A G J, Kok, N F M, Kuhlmann, K F D, Boot, H, Chalabi, M, Kruijff, S, Been, L B, van Ginkel, R J, de Groot, D J A, Fehrmann, R S N, de Wilt, J H W, Bremers, A J A, de Reuver, P R, Radema, S A, Herbschleb, K H, van Grevenstein, W M U, Witkamp, A J, Koopman, M, Haj Mohammad, N, van Duyn, E B, Mastboom, W J B, Mekenkamp, L J M, Nederend, J, Lahaye, M J, Snaebjornsson, P, Verhoef, C, van Laarhoven, H W M, Zwinderman, A H, Bouma, J M, Kranenburg, O, van 't Erve, I, Fijneman, R J A, Dijkgraaf, M G W, Hemmer, P H J, Punt, C J A, Tanis, P J & de Hingh, I H J T 2019, ' Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: Protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6) ', BMC Cancer, vol. 19, no. 1, 390 . https://doi.org/10.1186/s12885-019-5545-0Test
    BMC Cancer, 19:390. BioMed Central Ltd.
    BMC Cancer, 19:390. BMC
    BMC Cancer, 19(1):390. BioMed Central
    BMC Cancer, Vol 19, Iss 1, Pp 1-15 (2019)

    مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Clinical Trial, Phase III, Leucovorin, STAGE-II, Clinical Trial, Phase II, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Adjuvant/adverse effects, Neoplasm Metastasis, Neoadjuvant therapy, Bevacizumab/administration & dosage, COLON-CANCER, Progression-free survival, Colorectal Neoplasms/drug therapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cytoreduction surgical procedures, Clinical Trial, Combined Modality Therapy, Phase II, Oxaliplatin, Bevacizumab, Fluorouracil/administration & dosage, Oncology, Chemotherapy, Adjuvant, Randomized controlled trial, 030220 oncology & carcinogenesis, Cytoreduction Surgical Procedures/adverse effects, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, Fluorouracil, HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY, Peritoneum, medicine.drug, Randomized control trial, Adult, medicine.medical_specialty, MITOMYCIN-C, lcsh:RC254-282, Disease-Free Survival, Colorectal neoplasms, induced, LIVER METASTASES, 03 medical and health sciences, Phase III, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, medicine, Genetics, Journal Article, Chemotherapy, Humans, Hyperthermia, Mortality, Perioperative Period, business.industry, Peritoneum/drug effects, Perioperative, Peritoneal Neoplasms/drug therapy, Surgery, Adjuvant chemotherapy, Irinotecan, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Peritoneal neoplasms, 1ST-LINE TREATMENT, 030104 developmental biology, Hyperthermia, induced, Quality of Life, ADJUVANT TREATMENT, business, 5-FLUOROURACIL/FOLINIC ACID, PLUS BEVACIZUMAB

    وصف الملف: image/pdf; application/pdf

  6. 6

    المساهمون: Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Life Course Epidemiology (LCE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Clinical Cognitive Neuropsychiatry Research Program (CCNP), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

    المصدر: World Journal of Surgical Oncology
    World journal of surgical oncology, 17(1):14
    World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-7 (2019)

    وصف الملف: application/pdf

  7. 7

    المساهمون: Academic Medical Center, APH - Methodology, APH - Personalized Medicine, Medical Oncology, Medical oncology, CCA - Cancer Treatment and quality of life, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Nature, 574(7776), 127-131. Nature Publishing Group
    van der Velden, D L, Hoes, L R, van der Wijngaart, H, van Berge Henegouwen, J M, van Werkhoven, E, Roepman, P, Schilsky, R L, de Leng, W W J, Huitema, A D R, Nuijen, B, Nederlof, P M, van Herpen, C M L, de Groot, D J A, Devriese, L A, Hoeben, A, de Jonge, M J A, Chalabi, M, Smit, E F, de Langen, A J, Mehra, N, Labots, M, Kapiteijn, E, Sleijfer, S, Cuppen, E, Verheul, H M W, Gelderblom, H & Voest, E E 2019, ' The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs ', Nature, vol. 574, no. 7776, pp. 127-131 . https://doi.org/10.1038/s41586-019-1600-xTest
    Nature, 574(7776), 127. Nature Publishing Group
    Nature, 574, 7776, pp. 127
    Nature, 574(7776), 127-+. Nature Publishing Group
    Nature, 574, 127-131. Nature Publishing Group
    Nature, 574(7776), 127
    Nature, 574, 127

    وصف الملف: image/pdf; application/pdf

  8. 8

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Life Course Epidemiology (LCE), ​Robotics and image-guided minimally-invasive surgery (ROBOTICS)

    المصدر: Annals of Surgical Oncology, 22(2), 552-556. SPRINGER